These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12824949)

  • 41. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.
    Masquelier B; Pereira E; Peytavin G; Descamps D; Reynes J; Verdon R; Fleury H; Garraffo R; Chêne G; Raffi F; Brun-Vézinet F;
    J Clin Virol; 2005 May; 33(1):75-8. PubMed ID: 15797369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
    Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study on mutations and antiretroviral therapy (SMART): preliminary results.
    Gianotti N; Moretti F; Tambussi G; Racca S; Presi S; Crucianelli R; Carrera P; Ferrari M; Lazzarin A
    Antivir Ther; 1999; 4 Suppl 3():65-9. PubMed ID: 16021873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.
    Di Giambenedetto S; Bracciale L; Colafigli M; Cattani P; Pinnetti C; Bacarelli A; Prosperi M; Fadda G; Cauda R; De Luca A
    Antivir Ther; 2007; 12(5):835-9. PubMed ID: 17713168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV-1 drug resistance in Thailand: before and after National Access to Antiretroviral Program.
    Sutthent R; Arworn D; Kaoriangudom S; Chokphaibulkit K; Chaisilwatana P; Wirachsilp P; Thiamchai V; Sirapraphasiri T; Tanprasertsuk S
    J Clin Virol; 2005 Dec; 34(4):272-6. PubMed ID: 16286051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.
    Stone DR; Corcoran C; Wurcel A; McGovern B; Quirk J; Brewer A; Sutton L; D'Aquila RT
    Clin Infect Dis; 2002 Oct; 35(7):883-6. PubMed ID: 12228827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low prevalence of antiretroviral resistance among HIV type 1-positive prisoners in the Southeast United States.
    Menezes P; Rosen D; Wohl DA; Kiziah N; Sebastian J; Eron JJ; White B
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):136-41. PubMed ID: 22966822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Highlights of the Fourth International Workshop on HIV Drug Resistance.
    Lange JM; deJong MD
    J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):25-7. PubMed ID: 11362748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Primary HIV drug resistance in a prison population. REPRICOVA-2 Study].
    García-Guerrero J; Herrero A; Bedia M; Araújo R; Castellano JC;
    Enferm Infecc Microbiol Clin; 2004 Jan; 22(1):29-31. PubMed ID: 14757005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prison legal matters: is prison neglect creating super HIV?
    Rodrigues T
    Newsline People AIDS Coalit N Y; 1998; ():34-5. PubMed ID: 11367506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals.
    Stephenson BL; Wohl DA; Golin CE; Tien HC; Stewart P; Kaplan AH
    Public Health Rep; 2005; 120(1):84-8. PubMed ID: 15736336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nearly one-third of prison inmates aren't gettng proper care.
    AIDS Policy Law; 1999 Oct; 14(20):7. PubMed ID: 11367062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV treatment and care among Italian inmates: a one-month point survey.
    Monarca R; Madeddu G; Ranieri R; Carbonara S; Leo G; Sardo M; Choroma F; Casari S; Marri D; Muredda AA; Nava FA; Babudieri S;
    BMC Infect Dis; 2015 Dec; 15():562. PubMed ID: 26653247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV transmission in correctional facility.
    Macher A; Kibble D; Wheeler D
    Emerg Infect Dis; 2006 Apr; 12(4):669-71. PubMed ID: 16704817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis.
    Uthman OA; Oladimeji O; Nduka C
    AIDS Care; 2017 Apr; 29(4):489-497. PubMed ID: 27582186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How fourteen anti-HIV drugs could provide more bang for the buck.
    Martinez LJ
    Res Initiat Treat Action; 2000 Jun; 6(2):19-22. PubMed ID: 11707874
    [No Abstract]   [Full Text] [Related]  

  • 59. Man denied HIV drugs loses claim against prison officials.
    AIDS Policy Law; 2006 Jun; 21(13):3. PubMed ID: 20066753
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV transmission in a state prison system, 1988-2005.
    Jafa K; McElroy P; Fitzpatrick L; Borkowf CB; Macgowan R; Margolis A; Robbins K; Youngpairoj AS; Stratford D; Greenberg A; Taussig J; Shouse RL; Lamarre M; McLellan-Lemal E; Heneine W; Sullivan PS
    PLoS One; 2009; 4(5):e5416. PubMed ID: 19412547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.